---
created: 2025-04-13
updated: 2025-04-13T10:53
id: io=-%sNV[-
specialty: pharmaco
specialty_id: 533
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::54-hepatitis-c-therapy
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::08-microbiology::28-antivirals
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::02-antivirals::10-hepatitis-c-therapy
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::07-antimicrobials::08-antivirals-hepatitis::ribavirin,sofosbuvir,simeprevir
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^fa-updates::fa2018
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
The goal of chronic HCV therapy is to establish a sustained virologic response; that HCV RNA is not detected by PCR for **6 months**

---

# Answer
